4//SEC Filing
Dorsey Brian 4
Accession 0001415889-24-021364
CIK 0001671858other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:30 PM ET
Size
8.9 KB
Accession
0001415889-24-021364
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-08-13−30,000→ 111,828 totalExercise: $0.64Exp: 2028-11-28→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-08-13$0.64/sh+30,000$19,200→ 36,024 total - Sale
Common Stock
2024-08-13$13.00/sh−30,000$390,000→ 6,024 total
Footnotes (3)
- [F1]Includes 2,159 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") on June 30, 2023, 1,013 shares acquired under the ESPP on December 29, 2023 and 2,852 shares acquired under the ESPP on June 29, 2024.
- [F2]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.
- [F3]Immediately exercisable.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001380762
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:30 PM ET
- Size
- 8.9 KB